# OnCo record virogin-biotech (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/virogin-biotech/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "virogin-biotech" ;
  schema:name "Virogin Biotech"@en ;
  schema:alternateName "Virogin Biotech Ltd."@en, "Virogin Biotech Canada Ltd"@en, "CNBG-Virogin Biotech (Shanghai) Ltd."@en, "Shanghai Virogin Biotech Co., Ltd."@en ;
  schema:description "Virogin Biotech makes oncolytic viruses: modified herpes viruses that infect and break open cancer cells and alert the immune system. Its medicines are in trials in liver and bile duct cancers and other advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/virogin-biotech/>, <https://www.virogin.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.virogin.com/>, <https://virogin.com/about/>, <https://clinicaltrials.gov/study/NCT07522476>, <https://clinicaltrials.gov/study/NCT07682870>, <https://clinicaltrials.gov/study/NCT04758897> ;
  schema:addressCountry "CA" ;
  onco:cancers <https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/hcc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/> .